Laxmi Organic Q2 FY27 Results (NSE: LXCHEM)
Signal: Margin expansion
The read
The operating inflection is real but sequentially incomplete: consolidated revenue accelerated to ₹10,827.26 million, +54.7% YoY, and EBITDA margin expanded to 9.9% from an estimated 5.3% YoY, yet EBITDA fell 5.6% QoQ and operating cash flow dropped to ₹216.19 million in H1FY27 from ₹1,481.27 million, leaving the recovery dependent on sustained volume/mix improvement and working-capital normalization.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,082.73 Cr | +54.7% | +11.8% |
| EBIT | ₹80.11 Cr | +363.8% | |
| Net profit | ₹57.01 Cr | +417.2% | |
| EBIT margin | 9.9% |
P&L walk
Consolidated revenue increased to ₹10,827.26 million, +54.7% YoY and +11.8% QoQ, while EBITDA rose to ₹1,070.06 million, +188.6% YoY, supported by lower raw-material and power intensity; PAT reached ₹570.07 million, +417.2% YoY, although EBITDA declined 5.6% QoQ.
Segments
The filing reports a single Chemical Business segment, but consolidated PAT of ₹570.07 million materially exceeded standalone PAT of ₹398.64 million, indicating that subsidiaries contributed ₹171.43 million of incremental group profit.
Research and educational content only. Not investment advice.